• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42055100-120
Device Problems Improper or Incorrect Procedure or Method (2017); Difficult or Delayed Activation (2577); Defective Device (2588); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/17/2022
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a mildly tortuous, moderately calcified superficial artery that had restenosed.A command es wire was crossed and a 5x100mm armada 35 balloon was advanced to the lesion to pre-dilatation.Then a 5.5x100mm supera stent was advanced to the lesion and deployment was initiated.However, during deployment, it was noted that the stent implant only deployed partially at first.After multiple attempts, the stent deployed completely, however the stent implant was noted as compressed and did not cover the entire target lesion as planned.The delivery system was not removed under fluoroscopy.Another 5.5x80mm supera was used to successfully complete the procedure and cover the entirety of the target lesion.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported difficult or delayed activation was unable to be confirmed due to the condition of the returned device.The reported defective device shortened was unable to be confirmed as the stent was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Reportedly, the delivery system was not removed under fluoroscopy.It should be noted that the supera peripheral stent system instructions for use states: under fluoroscopy, remove the device from the guide wire and evaluate the improved luminal quality of the treated area.The deviation of the ifu does not appear to have caused/contributed to the reported difficulties.It is possible that during stent deployment interaction with the mildly tortuous and moderately calcified anatomy and/or other devices resulted in the ratchet being unable to properly engage/fully deploy the stent; thus resulting in reported difficult or delayed activation; however this cannot be confirmed.Additionally, it is possible that the delivery system was slightly pushed distally as the stent was being deployed resulting in the reported defective device shortened/compressed stent; however, this could not be confirmed.The investigation determined a conclusive cause for the reported difficulties cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.H6, code 2976 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14946836
MDR Text Key295965476
Report Number2024168-2022-07310
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2024
Device Catalogue Number42055100-120
Device Lot Number2020761
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/06/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
7F, 40CM SHEATH.
-
-